(Q45222726)

11 December 2017

title

PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker (English)

1 reference

11 December 2017

0 references

Lucilla Nobbio

1

0 references

Lucio Santoro

object named as

Lucio Santoro

8

0 references

Giuseppe Lauria

object named as

Giuseppe Lauria

6

0 references

Mary Reilly

7

object named as

Mary M Reilly

1 reference

11 December 2017

Davide Visigalli

2

1 reference

11 December 2017

Davide Radice

3

1 reference

11 December 2017

Elisabetta Fiorina

4

1 reference

11 December 2017

Alessandra Solari

5

1 reference

11 December 2017

Angelo Schenone

9

1 reference

11 December 2017

Davide Pareyson

10

1 reference

11 December 2017

CMT-TRIAAL Group

11

1 reference

11 December 2017

language of work or name

English

0 references

publication date

8 May 2014

1 reference

11 December 2017

1 reference

11 December 2017

volume

137

1 reference

11 December 2017

issue

Pt 6

1 reference

11 December 2017

page(s)

1614-1620

1 reference

Mouse schwann cells need both NRG1 and cyclic AMP to myelinate

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Animal models and therapeutic prospects for Charcot-Marie-Tooth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Identification of drug modulators targeting gene-dosage disease CMT1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

PMP22 expression in dermal nerve myelin from patients with CMT1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Molecular dissection of the Schwann cell specific promoter of the PMP22 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Ultrastructural PMP22 expression in inherited demyelinating neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Copy number variation upstream of PMP22 in Charcot-Marie-Tooth disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

Origin of the de novo duplication in Charcot — Marie — Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): The study protocol [EudraCT no.: 2006-000032-27]

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWU071

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWU071

1 reference

11 December 2017

1 reference